Lung Cancer Deaths Drop | AYA | Rare Endometrial Cancer, Cancer Information Highlights, August 19, 2020

National Cancer Institute sent this bulletin at 08/19/2020 02:09 PM EDT
National Cancer Institute

Having trouble viewing this email? View it as a Web page.

Bookmark and Share
Cancer Information Highlights
From the National Cancer Institute
Updating you about cancer causes, prevention, screening, treatment, coping, and more
 
New from NCI
Trastuzumab May Help Women with Rare Endometrial Cancer Live Longer
graphic shows Trastuzumab, a monoclonal antibody, attaching to HER2 on the surface of cancer cells   A small clinical trial suggests that some women with an aggressive type of endometrial cancer may live longer if they receive a drug that is often used to treat breast cancer with high levels of the HER2 protein.
Health Problems among Teen and Young Adult Cancer Survivors
young woman speaking with health care provider   A study found that cancer survivors who were diagnosed as teens or young adults are more likely to develop a wide range of health problems than their peers who had not had cancer.
Fusion Proteins in Childhood Cancers
scientistworking on computer   Fusion proteins occur in cells in which a piece of one chromosome breaks off and attaches to another chromosome. Learn more about research on fusion proteins that drive the growth of many childhood cancers.
New Treatments Lead to Drop in Lung Cancer Mortality

The number of deaths from non-small cell lung cancer (NSCLC) has fallen sharply in recent years. A new study led by NCI researchers shows that the drop is most likely due to new targeted treatments and fewer new cases of NSCLC.
Video—NCI Cancer Research Data Commons

The NCI Cancer Research Data Commons helps scientists share and analyze data. Learn how this resource will help make progress against cancer.
FDA Approvals
New Drug for Diffuse Large B-Cell Lymphoma

We’ve added a new drug summary for tafasitamab-cxix (Monjuvi). It was recently approved by the Food and Drug Administration to treat certain types of relapsed or refractory diffuse large B-cell lymphoma in adults who cannot receive an autologous stem cell transplant.
 
Also of Interest
Managing Costs and Medical Information

Keeping track of cancer tests and treatments, paperwork, bills, and other records can seem overwhelming. Learn ways to help manage medical costs and information.
Infographic—Finding New Ways to Help the Immune System Fight Cancer

Immunotherapy helps a person's own immune system find and kill cancer cells. This graphic shows the different ways that researchers are tapping into the immune system to target cancer.
Contact Us for Help

Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email.